AI Analysis AI Analysis of HBIO AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add HBIO to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Harvard Bioscience stock price down 3.07% on Friday
(Updated on Jul 24, 2026)

Sell candidate since Jul 22, 2026 Loss -2.12%

The Harvard Bioscience stock price fell by -3.07% on the last day (Friday, 24th Jul 2026) from $6.19 to $6.00. During the last trading day the stock fluctuated 3.33% from a day low at $6.00 to a day high of $6.20. The price has fallen in 6 of the last 10 days and is down by -2.28% for this period. Volume has increased on the last day by 2 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 6 thousand shares were bought and sold for approximately $36.13 thousand.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Harvard Bioscience stock with a 90% probability to be traded between $4.89 and $6.53 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

HBIO Signals & Forecast

There are few to no technical positive signals at the moment. The Harvard Bioscience stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $6.12 and $6.13. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 11, 2026, and so far it has fallen -9.64%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Harvard Bioscience gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Harvard Bioscience stock

Harvard Bioscience finds support from accumulated volume at $5.95 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.200 (3.33%) between high and low. For the last week, the stock has had daily average volatility of 3.39%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HBIO) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect Harvard Bioscience to open at $6.07, and during the day (based on 14 day Average True Range), to move between $5.86 and $6.14, which gives a possible trading interval of +/-$0.287 (+/-4.89%) up or down from last closing price. If Harvard Bioscience takes out the full calculated possible swing range there will be an estimated 4.89% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.95 (0.83%) than the resistance at $6.08 (1.33%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Harvard Bioscience stock A Buy?

Harvard Bioscience holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.122 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $6.07 ( 1.11%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

HBIO Performance

Trading levels for HBIO

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 6.27 4.44%
R2 6.19 3.17%
R1 6.14 2.38%
Price 6.00
S1 5.99 -0.162%
S2 5.94 -0.95%
S3 5.87 -2.22%

Accumulated Volume Support & Resistance Levels

Level Price
R3 7.24 20.67%
R2 6.40 6.67%
R1 6.08 1.33%
Price 6.00
S1 5.95 -0.83%
S2 5.41 -9.83%
S3 5.00 -16.67%

FAQ

What is the symbol for Harvard Bioscience Stock and on which exchange is it traded?
The symbol for Harvard Bioscience is HBIO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Harvard Bioscience Stock?
Harvard Bioscience holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Harvard Bioscience Stock?
Harvard Bioscience Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Harvard Bioscience Stock.

What's the current price of Harvard Bioscience Stock?
As of the end of day on the Jul 24, 2026, the price of an Harvard Bioscience (HBIO) share was $6.00.

What is the 52-week high and low for Harvard Bioscience Stock?
The 52-week high for Harvard Bioscience Stock is $9.40 and the 52-week low is $3.78.

What is the market capitalization of Harvard Bioscience Stock?
As of the Jul 24, 2026, the market capitalization of Harvard Bioscience is 27.061M.

When is the next earnings date for Harvard Bioscience?
The upcoming earnings date for Harvard Bioscience is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT HARVARD BIOSCIENCE
Harvard Bioscience
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgic...
GOLDEN STAR
Ticker Change Signal Date
KMT
$34.39
2.44% Jul 21
DHT
$17.31
6.59% Jul 13
NMRK
$15.02
2.46% Jun 24
JLL
$299.78
8.56% Jun 24
ROP
$331.60
10.78% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE